NZD 32.04
(1.49%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.51 Billion | 909.2 Million | 634.6 Million | 267.6 Million | 844.25 Million | 623.75 Million |
Net Income | 549.1 Million | 795.9 Million | 560 Million | -484.9 Million | 382.8 Million | 560.41 Million |
Depreciation & Amortization | 440.1 Million | 427.9 Million | 361.3 Million | 402 Million | 364.1 Million | 236.08 Million |
Deferred income taxes | -849.8 Million | 1.4 Billion | 1.34 Billion | -1.34 Billion | 786.74 Million | - |
Stock-based compensation | 3.3 Million | 25.6 Million | 3.4 Million | -1.6 Million | 2.51 Million | 2.81 Million |
Change in working capital | 846.5 Million | -1.42 Billion | -1.34 Billion | 1.34 Billion | -789.3 Million | -261.17 Million |
Other non-cash items | 522.6 Million | -314.6 Million | -286.7 Million | 350.5 Million | 97.4 Million | 58.35 Million |
Investing Cash Flow | -576.72 Million | -1.63 Billion | -319.2 Million | 462.6 Million | -138.94 Million | -425.57 Million |
Investments in PPE | -580.7 Million | -359.4 Million | -290.2 Million | -162.2 Million | -232.68 Million | -314.3 Million |
Acquisitions | -2.04 Million | -10.3 Million | -1.5 Million | 682 Million | - | -1.17 Million |
Investment purchases | -13.24 Million | -1.8 Million | - | -12.7 Million | - | -115.35 Million |
Sales/Maturities of investments | 24.98 Million | 43.2 Million | - | 24.8 Million | - | -16.57 Million |
Other Investing Activities | -5.7 Million | -1.3 Billion | -27.5 Million | -69.3 Million | 93.73 Million | 21.83 Million |
Financing Cash Flow | -839.77 Million | 266.5 Million | -120.9 Million | -391.8 Million | -679.02 Million | -222.93 Million |
Debt repayment | -12.97 Billion | -10.1 Billion | -7.92 Billion | -9.76 Billion | -10.55 Billion | -7.37 Billion |
Dividends payments | -595.6 Million | -383.6 Million | -178.7 Million | -189.8 Million | -239 Million | -309.35 Million |
Common Stock Repurchased | - | - | -300.4 Million | - | -260.15 Million | - |
Common Stock Issuance | - | - | 8.42 Billion | - | 10.48 Billion | - |
Other Financing Activities | 12.83 Billion | 10.79 Billion | -100.3 Million | 9.56 Billion | -109.54 Million | 7.46 Billion |
Accounts receivables | 239.5 Million | -546.7 Million | -635.6 Million | 588.9 Million | -295.9 Million | -258.79 Million |
Accounts payables | -47.8 Million | -42.4 Million | 65 Million | -350 Million | -5.1 Million | - |
Inventory | 607 Million | -882.8 Million | -710.6 Million | 755.2 Million | -493.4 Million | 78.79 Million |
Other working capital | 47.8 Million | 42.4 Million | -65 Million | 350 Million | 5.1 Million | -81.16 Million |
Cash at beginning of period | 111.44 Million | 566.3 Million | 367.6 Million | 35 Million | 6.14 Million | 44.52 Million |
Cash at end of period | 323.67 Million | 103.5 Million | 566.3 Million | 367.6 Million | 35.01 Million | 6.14 Million |
Capital Expenditure | -580.7 Million | -359.4 Million | -290.2 Million | -162.2 Million | -232.68 Million | -314.3 Million |
Effect of forex changes on cash | 861.41 Thousand | -6.5 Million | 4.2 Million | -5.8 Million | 2.58 Million | -13.62 Million |
Net cash flow / Change in cash | 212.23 Million | -462.8 Million | 198.7 Million | 332.6 Million | 28.87 Million | -38.37 Million |
Free Cash Flow | 931.09 Million | 549.8 Million | 344.4 Million | 105.4 Million | 611.57 Million | 309.44 Million |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 549.1 Million | 235 Million | 235 Million | 39.55 Million | 39.55 Million | 795.9 Million |
Depreciation & Amortization | 440.1 Million | 109.2 Million | 109.2 Million | 110.85 Million | 110.85 Million | 427.9 Million |
Deferred income taxes | -849.8 Million | -424.9 Million | -424.9 Million | - | - | 1.4 Billion |
Stock-based compensation | 3.3 Million | 1.65 Million | 1.65 Million | - | - | 25.6 Million |
Change in working capital | 846.5 Million | 447.15 Million | 447.15 Million | - | - | -1.42 Billion |
Other non-cash items | 522.6 Million | -386.15 Million | -386.15 Million | 198.65 Million | 198.65 Million | -314.6 Million |
Investing Cash Flow | -576.72 Million | -188.75 Million | -188.75 Million | -79.05 Million | -79.05 Million | -1.63 Billion |
Investments in PPE | -580.7 Million | -196.2 Million | -196.2 Million | -76.1 Million | -76.1 Million | -359.4 Million |
Acquisitions | -2.04 Million | - | - | -950 Thousand | -950 Thousand | -10.3 Million |
Investment purchases | -13.24 Million | - | - | -10.53 Million | - | -1.8 Million |
Sales/Maturities of investments | 24.98 Million | - | - | -2.28 Million | - | 43.2 Million |
Other Investing Activities | -5.7 Million | 7.45 Million | 7.45 Million | -2 Million | -2 Million | -1.3 Billion |
Financing Cash Flow | -839.77 Million | -117.9 Million | -117.9 Million | -272.05 Million | -272.05 Million | 266.5 Million |
Debt repayment | -12.97 Billion | - | - | -100.65 Million | - | -10.1 Billion |
Dividends payments | -595.6 Million | -113.1 Million | -113.1 Million | -184.7 Million | -184.7 Million | -383.6 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 12.83 Billion | -4.8 Million | -4.8 Million | -87.35 Million | -87.35 Million | 10.79 Billion |
Accounts receivables | 239.5 Million | 119.75 Million | 119.75 Million | - | - | -546.7 Million |
Accounts payables | -47.8 Million | - | - | - | - | -42.4 Million |
Inventory | 607 Million | 303.5 Million | 303.5 Million | - | - | -882.8 Million |
Other working capital | 47.8 Million | 23.9 Million | 23.9 Million | - | - | 42.4 Million |
Cash at beginning of period | 111.44 Million | - | - | 135.23 Million | - | 566.3 Million |
Cash at end of period | 323.67 Million | 100.85 Million | 100.85 Million | 107.38 Million | -2.3 Million | 103.5 Million |
Capital Expenditure | -580.7 Million | -196.2 Million | -196.2 Million | -76.1 Million | -76.1 Million | -359.4 Million |
Effect of forex changes on cash | 861.41 Thousand | 650 Thousand | 650 Thousand | -250 Thousand | -250 Thousand | -6.5 Million |
Net cash flow / Change in cash | 212.23 Million | 100.85 Million | 100.85 Million | -27.85 Million | -2.3 Million | -462.8 Million |
Free Cash Flow | 931.09 Million | 210.65 Million | 210.65 Million | 272.95 Million | 272.95 Million | 549.8 Million |
RSI
7112
CLN
IVP
PCTY
MEDX